These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29164610)

  • 21. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
    Castrillo JI; Lista S; Hampel H; Ritchie CW
    Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between comorbidity burden and rapid cognitive decline in individuals with mild to moderate Alzheimer's disease.
    Aubert L; Pichierri S; Hommet C; Camus V; Berrut G; de Decker L
    J Am Geriatr Soc; 2015 Mar; 63(3):543-7. PubMed ID: 25752337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers.
    Dong A; Toledo JB; Honnorat N; Doshi J; Varol E; Sotiras A; Wolk D; Trojanowski JQ; Davatzikos C;
    Brain; 2017 Mar; 140(3):735-747. PubMed ID: 28003242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential benefits of mindfulness-based interventions in mild cognitive impairment and Alzheimer's disease: an interdisciplinary perspective.
    Larouche E; Hudon C; Goulet S
    Behav Brain Res; 2015 Jan; 276():199-212. PubMed ID: 24893317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Use of Neuroimaging to Assess Associations Among Diet, Nutrients, Metabolic Syndrome, and Alzheimer's Disease.
    Pistollato F; Cano SS; Elio I; Vergara MM; Giampieri F; Battino M
    J Alzheimers Dis; 2015; 48(2):303-18. PubMed ID: 26401997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes and Alzheimer's disease crosstalk.
    Baglietto-Vargas D; Shi J; Yaeger DM; Ager R; LaFerla FM
    Neurosci Biobehav Rev; 2016 May; 64():272-87. PubMed ID: 26969101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.
    Hao K; Di Narzo AF; Ho L; Luo W; Li S; Chen R; Li T; Dubner L; Pasinetti GM
    Mol Aspects Med; 2015; 43-44():66-76. PubMed ID: 26116273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease.
    Kim J; Schweizer TA; Fischer CE; Munoz DG
    J Alzheimers Dis; 2017; 55(1):381-389. PubMed ID: 27662301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation: the link between comorbidities, genetics, and Alzheimer's disease.
    Newcombe EA; Camats-Perna J; Silva ML; Valmas N; Huat TJ; Medeiros R
    J Neuroinflammation; 2018 Sep; 15(1):276. PubMed ID: 30249283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth factors, AGEing, and the diabetes link in Alzheimer's disease.
    Loy CT; Twigg SM
    J Alzheimers Dis; 2009; 16(4):823-31. PubMed ID: 19387115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy.
    Fakhoury M
    Curr Neuropharmacol; 2018; 16(5):508-518. PubMed ID: 28730967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effects of geniposide on Alzheimer's disease pathology.
    Liu W; Li G; Hölscher C; Li L
    Rev Neurosci; 2015; 26(4):371-83. PubMed ID: 25879319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diet and Inflammation in Alzheimer's Disease and Related Chronic Diseases: A Review.
    Gardener SL; Rainey-Smith SR; Martins RN
    J Alzheimers Dis; 2016; 50(2):301-34. PubMed ID: 26682690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.
    Ishii M; Iadecola C
    Cell Metab; 2015 Nov; 22(5):761-76. PubMed ID: 26365177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The basis for disease-modifying treatments for Alzheimer's disease: the Sixth Annual Mild Cognitive Impairment Symposium.
    Duara R; Barker W; Loewenstein D; Bain L
    Alzheimers Dement; 2009 Jan; 5(1):66-74. PubMed ID: 19118811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.
    Adiele RC; Adiele CA
    J Alzheimers Dis; 2016 Jul; 53(4):1257-70. PubMed ID: 27392851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Gut Microbiota and Alzheimer's Disease.
    Jiang C; Li G; Huang P; Liu Z; Zhao B
    J Alzheimers Dis; 2017; 58(1):1-15. PubMed ID: 28372330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Medical comorbidity in Alzheimer's disease: baseline characteristics of the REAL.FR Cohort].
    Artaz MA; Boddaert J; Hériche-Taillandier E; Dieudonné B; Verny M;
    Rev Med Interne; 2006 Feb; 27(2):91-7. PubMed ID: 16359758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
    Kidd PM
    Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.